全球糖尿病黄斑水肿治疗市场 - 行业趋势及 2029 年预测

请求目录 请求目录 与分析师交谈 与分析师交谈 立即购买 立即购买 购买前请咨询 提前咨询 免费样本报告 免费样本报告

全球糖尿病黄斑水肿治疗市场 - 行业趋势及 2029 年预测

  • Pharmaceutical
  • Upcoming Report
  • Jan 2022
  • Global
  • 350 页面
  • 桌子數: 60
  • 图号: 220

Global Diabetic Macular Edema Treatment Market

市场规模(十亿美元)

CAGR :  % Diagram

Diagram Forecast Period
2023 –0
Diagram Market Size (Base Year)
USD MILLION
Diagram Market Size (Forecast Year)
USD MILLION
Diagram CAGR
%
Diagram Major Markets Players
  • F. Hoffmann-La Roche Ltd
  • Novartis AG
  • GlaxoSmithKline plc
  • Alimera Sciences
  • ALLERGAN

>全球糖尿病黄斑水肿治疗市场,按适应症类型(弥漫性糖尿病黄斑水肿和局灶性糖尿病黄斑水肿)、治疗类型(血管内皮生长因子 (VEGF)、皮质类固醇、激光光凝治疗和其他标签外药物)、药物输送(玻璃体内注射和玻璃体内植入)、最终用户(医院、诊所和家庭护理)、国家(美国、加拿大、墨西哥、巴西、阿根廷、秘鲁、南美洲其他地区、德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、匈牙利、立陶宛、奥地利、爱尔兰、挪威、波兰、欧洲其他地区、中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、越南、亚太其他地区、沙特阿拉伯、阿联酋、埃及、以色列、科威特、南非、中东和非洲其他地区)行业趋势和预测到 2029 年。

糖尿病黄斑水肿治疗市场

市场分析与洞察全球糖尿病黄斑水肿治疗市场

糖尿病性黄斑水肿治疗市场预计将在 2022-2029 年的预测期内实现市场增长。Data Bridge Market Research 分析称,在上述预测期内,市场复合年增长率为 3.65%,到 2029 年可能达到 6333 万的估值。糖尿病人口的增长导致患者出现糖尿病性黄斑水肿,这将有助于糖尿病性黄斑水肿治疗市场的增长。

黄斑水肿是一种液体和蛋白质积聚在眼睛黄斑上或黄斑下并导致肿胀的疾病。由于这种肿胀,人的中央视力会变得扭曲。囊样黄斑水肿 (CME) 和糖尿病性黄斑水肿 (DME) 是黄斑水肿 (DME) 的两种类型。糖尿病性黄斑水肿是糖尿病视网膜病变患者视力丧失的主要原因。据说糖尿病患者一生中患上这种疾病的几率为 10%。

在 2022-2029 年的预测期内,糖尿病性黄斑水肿治疗的新创新研发很可能加速糖尿病性黄斑水肿治疗市场的增长。另一方面,眼科手术技术的进步和制药公司的研发投资将进一步推动各种机会,从而导致预测期内糖尿病性黄斑水肿治疗市场的增长。

推动全球糖尿病黄斑水肿治疗市场增长的其他因素包括制药公司对研发的大量投入以及眼科手术技术的进步。

然而,患者高昂的医疗费用和频繁就医可能会在预测期内阻碍糖尿病性黄斑水肿治疗市场的增长。认知度的降低将在上述预测期内进一步挑战市场。

This diabetic macular edema treatment market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the diabetic macular edema treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Diabetic Macular Edema Treatment Market Scope and Market Size

Diabetic macular edema treatment market is segmented on the basis of indication type, treatment type, drug delivery and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

  • Based on indication type, the diabetic macular edema treatment market is segmented into diffuse diabetic macular edema and focal diabetic macular edema.
  • On the basis of treatment type, the diabetic macular edema treatment market is segmented into vascular endothelial growth factor (VEGF), corticosteroids, laser photocoagulation therapy, and other off-label drugs.
  • On the basis of drug delivery, the diabetic macular edema treatment market is segmented into intravitreal injections and intravitreal implants.
  • Diabetic macular edema treatment market has also been segmented based on the end user into hospitals, clinics and home care.

Diabetic Macular Edema treatment Market Country Level Analysis

Diabetic macular edema treatment market is analyzed and market size information is provided by the country, basis of indication type, treatment type, drug delivery and end user as referenced above.

The countries covered in the diabetic macular edema treatment market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.

North America dominates the diabetic macular edema treatment market due to the presence of major key players, increasing the penetration of episodic treatments, increasing number of patients with type 2 diabetes and the presence of a top-tier photocoagulation laser. Asia-Pacific is expected to grow during the forecast period of 2022-2029 due to the increasing patient pool, rising investment in the healthcare sector, and growing government support. The presence of major and domestic manufacturers of photocoagulation lasers will further contribute to the market growth.

The country section of the diabetic macular edema treatment market report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

Diabetic macular edema treatment market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to diabetic macular edema treatment market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the diabetic macular edema treatment market in the growth period.

Competitive Landscape and Global Diabetic Macular Edema Treatment Market Share Analysis

Diabetic macular edema treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to diabetic macular edema treatment market research.

糖尿病性黄斑水肿治疗市场的一些主要参与者包括 F. Hoffmann-La Roche Ltd、Novartis AG、GlaxoSmithKline plc、Alimera Sciences、ALLERGAN、Regeneron Pharmaceuticals Inc.、Pfizer Inc.、Kubota Pharmaceutical Holdings Co. Ltd.、Oculis、Bayer AG、Bausch & Lomb Incorporated、The National Eye Institute、Medytox、Smith+Nephew、Sanofi、Novartis AG、Teva Pharmaceutical Industries Ltd.、LGM Pharma.、Lannett 和 NorthStar Rx LLC 等。


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

Diabetic Macular Edema Treatment Market to grow at a CAGR 3.65% by forecast 2029.
Diabetic Macular Edema Treatment Market value to reach 63.33 million by forecast 2029.
The countries covered in the diabetic macular edema treatment market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.
Major players operating in the diabetic macular edema treatment market are F. Hoffmann-La Roche Ltd, Novartis AG, GlaxoSmithKline plc, Alimera Sciences, ALLERGAN, Regeneron Pharmaceuticals Inc., Pfizer Inc., Kubota Pharmaceutical Holdings Co. Ltd., Oculis, Bayer AG, Bausch & Lomb Incorporated, The National Eye Institute, Medytox, Smith+Nephew, Sanofi, Novartis AG, Teva Pharmaceutical Industries Ltd., LGM Pharma., Lannett and NorthStar Rx LLC.